Pirje Hütt, Eleri Lapp, Jelena Štšepetova, Imbi Smidt, Heleri Taelma, Natalja Borovkova, Helen Oopkaup, Ave Ahelik, Tiiu Rööp, Dagmar Hoidmets, Külli Samuel, Andres Salumets, Reet Mändar
{"title":"Characterisation of probiotic properties in human vaginal lactobacilli strains.","authors":"Pirje Hütt, Eleri Lapp, Jelena Štšepetova, Imbi Smidt, Heleri Taelma, Natalja Borovkova, Helen Oopkaup, Ave Ahelik, Tiiu Rööp, Dagmar Hoidmets, Külli Samuel, Andres Salumets, Reet Mändar","doi":"10.3402/mehd.v27.30484","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vaginal lactobacilli offer protection against recurrent urinary infections, bacterial vaginosis, and vaginal candidiasis.</p><p><strong>Objective: </strong>To characterise the isolated vaginal lactobacilli strains for their probiotic properties and to compare their probiotic potential.</p><p><strong>Methods: </strong>The Lactobacillus strains were isolated from vaginal samples by conventional culturing and identified by sequencing of the 16S rDNA fragment. Several functional properties were detected (production of hydrogen peroxide and lactic acid; antagonistic activity against Escherichia coli, Candida albicans, Candida glabrata, and Gardnerella vaginalis; auto-aggregation and adhesiveness) as well as safety (haemolytic activity, antibiotic susceptibility, presence of transferrable resistance genes).</p><p><strong>Results: </strong>A total of 135 vaginal lactobacilli strains of three species, Lactobacillus crispatus (56%), Lactobacillus jensenii (26%), and Lactobacillus gasseri (18%) were characterised using several functional and safety tests. Most of L. crispatus (89%) and L. jensenii (86%) strains produced H2O2. The best lactic acid producers were L. gasseri (18.2±2.2 mg/ml) compared to L. crispatus (15.6±2.8 mg/ml) and L. jensenii (11.6±2.6 mg/ml) (p<0.0001; p<0.0001, respectively). L. crispatus strains showed significantly higher anti-E. coli activity compared to L. jensenii. L. gasseri strains expressed significantly lower anticandidal activity compared to L. crispatus and L. jensenii (p<0.0001). There was no significant difference between the species in antagonistic activity against G. vaginalis. Nearly a third of the strains were able to auto-aggregate while all the tested strains showed a good ability to adhere to HeLa cells. None of the tested lactobacilli caused haemolysis. Although phenotypical resistance was not found to ampicillin, chloramphenicol, erythromycin, gentamycin, tetracycline, and vancomycin, the erm(B), tet(M), and tet(K) were detected in some strains. All strains were resistant to metronidazole, trimethoprim/sulfamethoxazole, and kanamycin.</p><p><strong>Conclusions: </strong>Our study revealed that the production of different antimicrobial metabolites is highly strain-specific and that the metabolites are not correlated with each other. L. crispatus displays better antagonistic activity against E. coli and Candida spp. than L. gasseri and L. jensenii; therefore; a potential probiotic candidate could be found among L. crispatus strains.</p>","PeriodicalId":18568,"journal":{"name":"Microbial Ecology in Health and Disease","volume":"27 ","pages":"30484"},"PeriodicalIF":0.0000,"publicationDate":"2016-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/3a/MEHD-27-30484.PMC4985617.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Ecology in Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3402/mehd.v27.30484","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Vaginal lactobacilli offer protection against recurrent urinary infections, bacterial vaginosis, and vaginal candidiasis.
Objective: To characterise the isolated vaginal lactobacilli strains for their probiotic properties and to compare their probiotic potential.
Methods: The Lactobacillus strains were isolated from vaginal samples by conventional culturing and identified by sequencing of the 16S rDNA fragment. Several functional properties were detected (production of hydrogen peroxide and lactic acid; antagonistic activity against Escherichia coli, Candida albicans, Candida glabrata, and Gardnerella vaginalis; auto-aggregation and adhesiveness) as well as safety (haemolytic activity, antibiotic susceptibility, presence of transferrable resistance genes).
Results: A total of 135 vaginal lactobacilli strains of three species, Lactobacillus crispatus (56%), Lactobacillus jensenii (26%), and Lactobacillus gasseri (18%) were characterised using several functional and safety tests. Most of L. crispatus (89%) and L. jensenii (86%) strains produced H2O2. The best lactic acid producers were L. gasseri (18.2±2.2 mg/ml) compared to L. crispatus (15.6±2.8 mg/ml) and L. jensenii (11.6±2.6 mg/ml) (p<0.0001; p<0.0001, respectively). L. crispatus strains showed significantly higher anti-E. coli activity compared to L. jensenii. L. gasseri strains expressed significantly lower anticandidal activity compared to L. crispatus and L. jensenii (p<0.0001). There was no significant difference between the species in antagonistic activity against G. vaginalis. Nearly a third of the strains were able to auto-aggregate while all the tested strains showed a good ability to adhere to HeLa cells. None of the tested lactobacilli caused haemolysis. Although phenotypical resistance was not found to ampicillin, chloramphenicol, erythromycin, gentamycin, tetracycline, and vancomycin, the erm(B), tet(M), and tet(K) were detected in some strains. All strains were resistant to metronidazole, trimethoprim/sulfamethoxazole, and kanamycin.
Conclusions: Our study revealed that the production of different antimicrobial metabolites is highly strain-specific and that the metabolites are not correlated with each other. L. crispatus displays better antagonistic activity against E. coli and Candida spp. than L. gasseri and L. jensenii; therefore; a potential probiotic candidate could be found among L. crispatus strains.
背景:阴道乳酸杆菌可预防反复泌尿感染、细菌性阴道病和阴道念珠菌病:阴道乳酸杆菌可预防复发性泌尿系统感染、细菌性阴道病和阴道念珠菌病:目的:分析分离出的阴道乳杆菌菌株的益生特性,并比较它们的益生潜力:方法:通过传统培养方法从阴道样本中分离乳酸杆菌菌株,并通过 16S rDNA 片段测序进行鉴定。检测了几种功能特性(过氧化氢和乳酸的产生;对大肠杆菌、白色念珠菌、光滑念珠菌和阴道加德纳菌的拮抗活性;自动聚集和粘附性)以及安全性(溶血活性、抗生素敏感性、可转移抗性基因的存在):结果:通过多项功能和安全性测试,共鉴定了 135 株阴道乳杆菌菌株,包括三种乳杆菌:脆片乳杆菌(56%)、简森乳杆菌(26%)和加塞利乳杆菌(18%)。大多数 L. crispatus(89%)和 L. jensenii(86%)菌株都能产生 H2O2。与 L. crispatus(15.6±2.8 毫克/毫升)和 L. jensenii(11.6±2.6 毫克/毫升)相比,L. gasseri(18.2±2.2 毫克/毫升)的乳酸产量最高:我们的研究表明,不同抗菌代谢物的产生具有高度的菌株特异性,而且这些代谢物之间没有关联。与 L. gasseri 和 L. jensenii 相比,L. crispatus 对大肠杆菌和念珠菌属具有更好的拮抗活性;因此,可以在 L. crispatus 菌株中找到潜在的益生菌候选菌株。